Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry

  • Anselm K. Gitt, Peter Bramlage, Sebastian A. Potthoff, Peter Baumgart, Felix Mahfoud, Hartmut Buhck, Martina Ehmen, Taoufik Ouarrak, Jochen Senges, Roland E. Schmieder
  • BMC Cardiovascular Disorders, March 2016, Springer Science + Business Media
  • DOI: 10.1186/s12872-016-0222-6

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Peter Bramlage